Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • approves

    Tag: approves

    You Searched For "approves"
    FDA approves first ever oral Semaglutide for blood sugar control in type 2 diabetes

    FDA approves first ever oral Semaglutide for blood sugar control in type 2 diabetes

    Dr. Kamal Kant Kohli Kohli20 Sept 2019 8:20 PM IST
    Food and Drug Administration has approved first GLP-1 oral drug Semaglutide for blood sugar control in type 2 diabetes.The U.S. Food and Drug...
    FDA approves first treatment for  rare vasculitis in children

    FDA approves first treatment for  rare vasculitis in children

    Dr. Kamal Kant Kohli Kohli28 Sept 2019 5:31 AM IST
    Food and Drug Administration has approved first treatment for rare vasculitis in children.The U.S. Food and Drug Administration today approved...
    FDA approves first drug to ease pain in phototoxic exposure  in  erythropoietic protoporphyria

    FDA approves first drug to ease pain in phototoxic exposure  in  erythropoietic protoporphyria

    Dr. Kamal Kant Kohli Kohli9 Oct 2019 7:05 PM IST
    Food and Drug Administration has approved first drug to ease phototoxic exposure in erythropoietic protoporphyria patients.The U.S. Food and Drug...
    FDA approves new drug for instant treatment of acute migraine

    FDA approves new drug for instant treatment of acute migraine

    Dr. Kamal Kant Kohli Kohli13 Oct 2019 7:05 PM IST
    Food and Drug Administration has approved a new drug for treating acute migraine in adults.The U.S. Food and Drug Administration today approved...
    FDA approves Dapagliflozin to reduce risk of Heart Failure in Diabetes

    FDA approves Dapagliflozin to reduce risk of Heart Failure in Diabetes

    Dr. Kamal Kant Kohli Kohli23 Oct 2019 7:20 PM IST
    Food and Drug Administration has approved Dapagliflozin to reduce the risk for Heart Failure Hospitalization in Diabetes.The US Food and Drug...
    FDA approves first treatment for anemia in thalessemia patients

    FDA approves first treatment for anemia in thalessemia patients

    Dr. Kamal Kant Kohli Kohli10 Nov 2019 9:45 AM IST
    FDA has approved first treatment for anemia in thalessemia patients.The U.S. Food and Drugs Administration has granted approval to Reblozyl...
    FDA approves cefiderocol for complicated UTIs including pyelonephritis

    FDA approves cefiderocol for complicated UTIs including pyelonephritis

    Dr. Kamal Kant Kohli Kohli15 Nov 2019 7:20 PM IST
    FDA has approved cefiderocol, a novel antibiotic for complicated urinary tract infections (cUTI), including pyelonephritis, in patients with limited...
    FDA approves first adjunctive drug to reduce CV risk in patients with elevated triglycerides

    FDA approves first adjunctive drug to reduce CV risk in patients with elevated triglycerides

    Dr. Kamal Kant Kohli Kohli13 Dec 2019 7:15 PM IST
    Food and drugs administration has approved first drug to reduce cardiovascular risk among patients with elevated triglyceride on maximum dose of...
    FDA approves tazarotene lotion for acne treatment

    FDA approves tazarotene lotion for acne treatment

    Dr. Kamal Kant Kohli Kohli22 Dec 2019 7:28 PM IST
    The U.S. Food and Drug Administration (FDA) has approved the New Drug Application for ARAZLOTM (tazarotene) Lotion, 0.045%, for the topical treatment...
    FDA approves first ever vaccine against ebola virus disease

    FDA approves first ever vaccine against ebola virus disease

    Dr. Kamal Kant Kohli Kohli20 Dec 2019 7:25 PM IST
    FDA has approved first ever vaccine against ebola virus disease.The U.S. Food and Drug Administration has announced approval of Ervebo first vaccine...
    FDA approves delafloxacin for specific cases of community-acquired bacterial pneumonia

    FDA approves delafloxacin for specific cases of community-acquired bacterial pneumonia

    Dr. Kamal Kant Kohli Kohli27 Oct 2019 7:28 PM IST
    The U.S. Food and Drug Administration (FDA) has approved BAXDELA® (delafloxacin) for the treatment of adult patients with community-acquired bacterial...
    FDA approves first treatment for cystic fibrosis

    FDA approves first treatment for cystic fibrosis

    Dr. Kamal Kant Kohli Kohli22 Oct 2019 7:15 PM IST
    Food and Drug Administration has approved first treatment for cystic fibrosis.The approval of new drug Trikafta has been granted to Vertex...
    Next

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 12 Oct 2022 7:06 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok